Hostname: page-component-7c8c6479df-xxrs7 Total loading time: 0 Render date: 2024-03-28T08:47:25.244Z Has data issue: false hasContentIssue false

Perplexed trainees – what do you follow: the NICE guidelines or clinical wisdom?

Published online by Cambridge University Press:  02 January 2018

Vinuthna Pemmaraju
Affiliation:
Oaklands Centre, Raddlebarn Road, Selly Oak, Birmingham B29 6JB, email: Vinutha@doctors.org.uk
Sasha Hvidsten
Affiliation:
Elms Centre, Halesowen, West Midlands
Rights & Permissions [Opens in a new window]

Abstract

Type
The columns
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 2008

We certainly agree with authors Hodes & Garralda (Psychiatric Bulletin October 2007, 31, 361–362) who observe that there are flaws in the National Institute for Health and Clinical Excellence (NICE) guidelines and a lack of available evidence for the treatment of depression in children and young people. During basic training in psychiatry, a trainee is encouraged to follow the NICE guidelines, Maudsley guidelines and others when initiating any intervention.

The same principle applies to the speciality of child and adolescent psychiatry. However, as a trainee in this speciality we have noticed that there are different factors that contribute to the use of pharmacological interventions.

As the authors mention, these trials demonstrated the benefit of fluoxetine over and above that of cognitive–behavioural therapy (CBT). This is supported by the TADS study (Reference March, Silva and PetryckiMarch et al, 2004) and by the ADAPT trial (www.iop.kcl.ac.uk/projects/?id=10095).

Another concern is the low availability of CBT as a first line treatment for adolescents with moderate to severe depression (Reference Perera, Gupta and SamuelPerera et al, 2007).

Consider the teenager presenting in crisis after an intentional overdose, or serious deliberate self-harm, following traumatic life events and family disruption. Thought must be given to the family's ability, resources and motivation to support the young person through CBT.

It is clear that the authors are not advocating indiscriminate prescribing of antidepressant medications, but it also seems that the NICE guidelines for depression do not fully appraise the ‘real world’ situation with respect to resources and patient choice.

We trust that NICE recognises this and plans a timely review of its recommendations. We continue to exercise our clinical acumen and review the available evidence when treating the young people that we see.

References

March, J., Silva, S., Petrycki, S., et al (2004) Fluoxetine, cognitive–behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) Team. JAMA, 292, 807820.Google Scholar
Perera, A., Gupta, P., Samuel, R., et al (2007) A survey of anti-depressant prescribing practice and the provision of psychological therapies in a south London CAMHS from 2003–2006. Child and Adolescent Mental Health, 12, 7072.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.